Difficulty: Medium
Average Score: 68%
Practice
With regard to oral anti-asthmatic agents:
Correct answer
C
Rationale
In the context of oral anti-asthmatic agents, option C, "cyclosporin's toxicity limits its use as an oral anti-asthmatic agent," is the correct answer. Cyclosporin is indeed associated with significant toxicity, including nephrotoxicity and hypertension, which restrict its widespread use in asthma management.
Option A, "prednisone is a long acting glucocorticoid," is incorrect because prednisone is a short- to intermediate-acting glucocorticoid commonly used for acute exacerbations rather than for long-term asthma control.
Option B, "methotrexate has been shown to be beneficial in prednisone-dependent asthmatics in all studies," is incorrect as methotrexate is not a first-line treatment for asthma and its efficacy in asthma management is not well-established.
Option D, "oral nifedipine significantly inhibits exercise-induced bronchoconstriction," is incorrect because nifedipine is a calcium channel blocker primarily used for cardiovascular conditions and has no significant role in managing asthma.
Understanding the limitations and appropriate use of different oral anti-asthmatic agents is crucial for nursing pharmacology students to ensure safe and effective patient care. Asthma management involves a multifaceted approach tailored to individual patient needs, considering factors such as efficacy, safety, and patient-specific characteristics to optimize outcomes and minimize adverse effects.
Option A, "prednisone is a long acting glucocorticoid," is incorrect because prednisone is a short- to intermediate-acting glucocorticoid commonly used for acute exacerbations rather than for long-term asthma control.
Option B, "methotrexate has been shown to be beneficial in prednisone-dependent asthmatics in all studies," is incorrect as methotrexate is not a first-line treatment for asthma and its efficacy in asthma management is not well-established.
Option D, "oral nifedipine significantly inhibits exercise-induced bronchoconstriction," is incorrect because nifedipine is a calcium channel blocker primarily used for cardiovascular conditions and has no significant role in managing asthma.
Understanding the limitations and appropriate use of different oral anti-asthmatic agents is crucial for nursing pharmacology students to ensure safe and effective patient care. Asthma management involves a multifaceted approach tailored to individual patient needs, considering factors such as efficacy, safety, and patient-specific characteristics to optimize outcomes and minimize adverse effects.